Americana Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Americana Partners's VRTX Position: Q2 2026 in Review

Americana Partners increased its Vertex Pharmaceuticals (VRTX) stake by 31% in Q2 2026, buying an estimated $4.05M and bringing the position to 38,914 shares worth $19.3M. The position accounts for 0.44% of the portfolio, ranked #54.

Americana Partners first reported a position in VRTX in Q4 2019 and has held it in 12 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

• Americana Partners held 38,914 shares of Vertex Pharmaceuticals worth $19.3M as of Q2 2026.
• Americana Partners bought 9,141 Vertex Pharmaceuticals shares in Q2 2026, an estimated $4.05M.
• Vertex Pharmaceuticals made up 0.44% of Americana Partners's portfolio in Q2 2026, its #54 holding.
• Americana Partners first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 12 quarters since.
• 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Americana Partners's 13F filing for Q2 2026, filed 5 Aug 2026.